Should a patient with nephrotic syndrome and possible deep‑vein thrombosis be allowed to walk or perform heel‑raise exercises?

Activity Restrictions in Nephrotic Syndrome with Possible DVT

A patient with nephrotic syndrome and possible deep vein thrombosis should NOT be restricted from walking or performing heel-raise exercises—in fact, early mobilization is safe and may help reduce acute symptoms, provided appropriate anticoagulation is initiated based on thrombotic risk stratification.

Immediate Management Algorithm

Step 1: Confirm DVT Status and Initiate Anticoagulation

• If DVT is confirmed: Start full-dose anticoagulation immediately (intravenous heparin bridging to warfarin, target INR 2-3) 1
• If DVT is suspected but not yet confirmed: Obtain urgent lower limb compression ultrasonography 2
• Note: Higher than usual heparin dosing may be required due to antithrombin III urinary loss in nephrotic syndrome 1

Step 2: Assess Prophylactic Anticoagulation Need

Even without confirmed DVT, prophylactic anticoagulation should be considered if the patient has:

• Serum albumin <20-25 g/L (using bromocresol green assay; use <20 g/L if bromocresol purple) AND any of:
  • Proteinuria >10 g/day
  • BMI >35 kg/m²
  • Prolonged immobilization
  • Recent orthopedic or abdominal surgery 1

Step 3: Mobilization Strategy

Early walking is safe and beneficial 3:

• Early exercise compared with bed rest shows similar short-term risk of pulmonary embolism in acute DVT
• Walking leads to more rapid resolution of limb pain
• A 6-month daily walking program produces similar vein recanalization rates as controls

Heel-raise exercises are appropriate 4:

• Ankle pump exercises (which include heel raises) significantly reduce DVT incidence (OR = 0.27, p < 0.001)
• These exercises improve maximum venous outflow and venous capacity
• They promote venous return and reduce limb swelling

Critical Caveats

Do NOT Restrict Mobility

The outdated practice of bed rest for DVT is contraindicated. Prolonged immobilization is itself listed as a risk factor for thrombosis in nephrotic syndrome 1. The evidence shows early mobilization is safe when anticoagulation is therapeutic 3.

Membranous Nephropathy Carries Highest Risk

If the underlying cause is membranous glomerulonephritis, this patient faces particularly high thromboembolic risk and warrants aggressive prophylaxis 1. Consider this when determining anticoagulation intensity.

Monitor for Bilateral DVT

Bilateral deep vein thrombosis, though uncommon, should prompt expanded evaluation for nephrotic syndrome as the underlying cause 2. If bilateral DVT is present, this represents extensive disease requiring full anticoagulation.

Practical Implementation

Immediate orders:

1. Continue or initiate therapeutic anticoagulation based on DVT confirmation
2. Encourage ambulation as tolerated—do not order bed rest
3. Prescribe ankle pump/heel-raise exercises: 10 repetitions every hour while awake
4. Check serum albumin (specify assay type), 24-hour urine protein, and bleeding risk assessment

Duration of activity: Full mobilization should begin immediately and continue throughout treatment. Exercise training programs of 6 months duration have shown benefit in preventing postthrombotic syndrome 3.

The convergence of evidence from KDIGO 2021 guidelines 1 and systematic reviews of DVT management 3 clearly supports early mobilization rather than restriction in this clinical scenario.